Bioleaders Corporation (142760) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.039x

Based on the latest financial reports, Bioleaders Corporation (142760) has a cash flow conversion efficiency ratio of -0.039x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-932.70 Million ≈ $-632.07K USD) by net assets (₩24.19 Billion ≈ $16.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 142760 market cap for the company's overall valuation and market capitalisation.

Bioleaders Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bioleaders Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioleaders Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioleaders Corporation ranked by their cash flow conversion efficiency. Explore Bioleaders Corporation (142760) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tigi Ltd TA:TIGI	2.123x
Noble Financials SA WAR:IBS	0.002x
Pacific Empire Minerals Corp F:1YK	-0.237x
Filtronic LSE:FTC	0.330x
Metro Realty Tbk JK:MTSM	-0.091x
Sipa Resources Ltd AU:SRI	-1.068x
Reborn Coffee Inc NASDAQ:REBN	0.105x
Renoworks Software Inc V:RW	5.279x

Annual Cash Flow Conversion Efficiency for Bioleaders Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2025. View Bioleaders Corporation stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩30.57 Billion ≈ $20.71 Million	₩-5.97 Billion ≈ $-4.05 Million	-0.195x	-1352.26%
2024-12-31	₩37.31 Billion ≈ $25.28 Million	₩-501.75 Million ≈ $-340.03K	-0.013x	-107.80%
2023-12-31	₩35.79 Billion ≈ $24.26 Million	₩6.18 Billion ≈ $4.18 Million	0.173x	+118.16%
2022-12-31	₩21.69 Billion ≈ $14.70 Million	₩-20.60 Billion ≈ $-13.96 Million	-0.950x	-751.07%
2021-12-31	₩45.11 Billion ≈ $30.57 Million	₩-5.04 Billion ≈ $-3.41 Million	-0.112x	+37.04%
2020-12-31	₩30.60 Billion ≈ $20.74 Million	₩-5.43 Billion ≈ $-3.68 Million	-0.177x	-92.34%
2019-12-31	₩23.82 Billion ≈ $16.14 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.092x	+75.30%
2018-12-31	₩23.50 Billion ≈ $15.92 Million	₩-8.77 Billion ≈ $-5.94 Million	-0.373x	-53.95%
2017-12-31	₩35.17 Billion ≈ $23.83 Million	₩-8.53 Billion ≈ $-5.78 Million	-0.242x	+45.00%
2016-12-31	₩17.46 Billion ≈ $11.83 Million	₩-7.70 Billion ≈ $-5.22 Million	-0.441x	+49.32%
2015-12-31	₩5.55 Billion ≈ $3.76 Million	₩-4.83 Billion ≈ $-3.27 Million	-0.870x	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$6.83 Million

₩10.08 Billion KRW

Market Cap Rank

#28039 Global

#2061 in Korea

Share Price

₩478.00

Change (1 day)

-2.45%

52-Week Range

₩349.00 - ₩1850.00

All Time High

₩24990.00